Status:

COMPLETED

A Study Based on Health Insurance Data About the Treatment of Patients Who Have Been Newly Diagnosed With Chronic Obstructive Pulmonary Disease (COPD)

Lead Sponsor:

Boehringer Ingelheim

Conditions:

Pulmonary Disease, Chronic Obstructive

Eligibility:

All Genders

40+ years

Brief Summary

A retrospective analysis study in COPD patients for an exact follow-up period of 12 months (in subgroup analyses: 24 and 36 months); censoring of patients will only be done in case a patient died duri...

Eligibility Criteria

Inclusion

  • All patients who were continuously insured by the sickness fund for the entire period (01/01/2013-30/06/2018) or, in case a patient deceased after index date, for the time until death
  • A patient will be included as an incident COPD patient if either a hospital documented at least one COPD diagnosis (International Statistical Classification of Diseases and Related Health Problems (ICD-10 J 44.-) or a specialist (pneumologist) documented at least 2 confirmed COPD diagnoses (above ICD-10) code) in two different quarters; the first of the above diagnoses is defined as index diagnosis; inclusion period is defined as lasting from 01/01/2014 until 30/06/2017
  • Patients should not have received any COPD diagnosis (ICD-10 J44.-) or any COPD-associated medication in the 12 months pre-index period
  • Patient should have, at date of incident COPD diagnosis (index date), an age of at least 40 years

Exclusion

  • Patients received , at least one confirmed inpatient asthma diagnosis or two confirmed outpatient diagnoses of asthma (ICD-10: J45) by pneumologists

Key Trial Info

Start Date :

November 20 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 1 2020

Estimated Enrollment :

17464 Patients enrolled

Trial Details

Trial ID

NCT04097223

Start Date

November 20 2019

End Date

July 1 2020

Last Update

February 24 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Institute for pharmacoeconomics and pharmaceutical logistics e.V (IPAM)

Wismar, Germany, 23966